Eszopiclone 3 mg/1 (Eszopiclone TABLET, FILM COATED) 3 mg/1

Eszopiclone works as a positive allosteric modulator of the GABA_A receptor at the benzodiazepine binding site. By enhancing chloride ion influx, it produces sedative-hypnotic effects, which help in reducing sleep latency and improving sleep maintenance. This mechanism is distinct from benzodiazepines, making it a non-benzodiazepine hypnotic.

The usual dose of Eszopiclone 3 mg is determined by a healthcare provider based on the patient's condition and response to the medication. The recommended starting dose is 1 mg, which can be increased to 2 mg or 3 mg if clinically indicated. The total dose should not exceed 3 mg once daily immediately before bedtime.

Eszopiclone is classified as a Category C drug for pregnancy, meaning that animal reproduction studies have shown an adverse effect on the fetus, and there are no adequate and well-controlled studies in humans. It should be used during pregnancy only if the potential benefits justify the potential risks. It is not known whether eszopiclone is excreted in human milk, so caution should be exercised when using it during breastfeeding.

To order Eszopiclone 3 mg from GNH India, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams across international markets. The team will ask you to confirm your trade or institutional credentials and will reply with pricing, availability, shipping, and the import paperwork.

Eszopiclone is a non-benzodiazepine hypnotic, which means it has a different mechanism of action compared to traditional benzodiazepines. It is less likely to cause dependence and has a lower risk of next-day impairment. However, it may still cause side effects such as dizziness, headache, and daytime drowsiness. The choice of sleep medication depends on individual patient factors and should be determined by a healthcare provider.

Eszopiclone 3 mg should be stored at room temperature, between 59°F to 86°F (15°C to 30°C). Keep the medication in the original pack and protect it from moisture. Ensure that it is stored out of reach of children and pets.

Eszopiclone 3 mg is administered orally, typically taken immediately before bedtime. It should be taken as directed by a healthcare provider. The medication should not be taken with or immediately after a high-fat meal, as this may reduce its effectiveness. It is important to follow the prescribed dosage and not to exceed the recommended dose.

The most serious risks associated with Eszopiclone 3 mg include complex sleep behaviors such as sleep-driving, memory impairment, and hallucinations. These risks are increased if the medication is taken with less than a full night of sleep remaining, if higher than the recommended dose is taken, or if it is co-administered with other CNS depressants. Patients should be monitored for these risks and should avoid activities that require full alertness the day after use.

Eszopiclone 3 mg should not be used by individuals who are allergic to eszopiclone or any of its inactive ingredients. It should be used with caution in elderly or debilitated patients, as well as in patients with severe hepatic impairment. It should also be avoided in patients with a history of complex sleep behaviors or those who have not had a full night of sleep. Pregnant or breastfeeding women should consult a healthcare provider before using eszopiclone.